BioSpace News Archive

Reference is made to the stock exchange notice published by Nordic Nanovector ASA on 3 July 2018 where the Company announced that the board of directors of the Company had resolved to increase the Company’s share capital in connection with the exercise of RSUs.

Stellar Biotechnologies, Inc. issued a statement on the favorable Phase 2b study results published by Neovacs, S.A., a customer and joint venture partner.

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that it has received a Decision to Grant notice from the Japanese Patent Office (“JPO”) to issue a patent entitled: “Methods of generating mesenchymal stem cells which secrete neurotrophic factors.”

Sagentia announces that it is now registered to ISO 13485:2016, receiving confirmation of the transition nearly a year ahead of the February 2019 deadline.

Adlai Nortye Biopharma Co., Ltd. (“Adlai Nortye” or “the Company”), a biopharmaceutical company, announced that it has raised $53 million in a Series B financing round.

Company to expand atrial fibrillation ablation therapy offerings with innovative cryoballoon platform

Live Webcast Scheduled for July 12, 2018, 10:00 AM ET, followed by Q&A

Test Offers Insight into Training Style and Nutritional Needs

The MSL of the Year Awards will raise visibility to what industry leading practice looks like.

$2M to Clear Guide Medical for Development of Pediatric Needle Guidance - better first-pass success for many clinicians